Oral Mucositis Gel
Formulated specifically for patients experiencing oral mucositis due to chemotherapy, radiation, or other conditions, Oral Mucositis Gel provides fast-acting, localized relief from pain, burning, and inflammation. This soothing, bioadhesive gel forms a protective barrier over mouth sores and irritated tissues, allowing healing to begin while minimizing discomfort during eating or speaking.
Type: Topical therapeutic gel (mouth paint, spray, cream)
Target: Head & neck cancer patients with chemo-/radiation-induced oral mucositis
Target Users:
- Patients
- Oncologists & dentists
- Hospitals & cancer clinics
Product Stage
Research & Development
Currently undergoing formulation and lab testing.
Clinical Trials
Status: Not Started
This stage will begin once R&D is complete.
Regulatory Review
Status: Upcoming
This step will follow successful clinical trials.
Market Launch
Status: Upcoming
This will mark the product’s official entry into the market.
Key Features
All-in-one treatment (antibacterial, antifungal, analgesic, antioxidant)
Cost-effective, non-cytotoxic, patient-friendly
Stable, pH-optimized, shear-thinning formulations
Market Entry
In vitro validation → Clinical trials
Regulatory approvals → Launch in oncology centers
Future global expansion via licensing
